Corventis
Company

Last deal

$10M

Amount

Series C

Stage

01.12.2009

Date

2

all rounds

$26.9M

Total amount

General

About Company
Corventis enables early detection of cardiovascular events, ensuring better clinical outcomes and lower healthcare costs.

Industry

Sector :

Subsector :

Keywords :

Also Known As

Amigo Therapy

founded date

01.01.1995

Number of employees

Company Type

For Profit

Last funding type

Series C

IPO status

Private

Description

The company develops non-invasive medical technologies focused on improving cardiovascular health. Their core product is a monitor that measures various aspects of heart function, allowing patients to maintain an active lifestyle while facilitating the timely detection of cardiovascular events. By combining innovation and patient-centric design, Corventis aims to enhance clinical outcomes and reduce healthcare expenses associated with cardiovascular diseases.
Contacts

Social url